Matches in Wikidata for { <http://www.wikidata.org/entity/Q89918114> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q89918114 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q89918114 description "scientific article published on 21 January 2020" @default.
- Q89918114 description "wetenschappelijk artikel" @default.
- Q89918114 description "наукова стаття, опублікована 21 січня 2020" @default.
- Q89918114 name "Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserve" @default.
- Q89918114 name "Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserve" @default.
- Q89918114 type Item @default.
- Q89918114 label "Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserve" @default.
- Q89918114 label "Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserve" @default.
- Q89918114 prefLabel "Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserve" @default.
- Q89918114 prefLabel "Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserve" @default.
- Q89918114 P1433 Q89918114-E4738390-E1B9-4B66-86D8-D7D1DD3E3E27 @default.
- Q89918114 P1476 Q89918114-3328CA89-3EAB-4B31-BCAF-A6CD3269BC2B @default.
- Q89918114 P2093 Q89918114-119E2C58-CD5B-440B-ACE2-9EE114E63780 @default.
- Q89918114 P2093 Q89918114-3F6E1486-B153-4FD7-9CA3-BBD1A7F2AADA @default.
- Q89918114 P2093 Q89918114-6109B8AE-94A9-4F6C-82C0-6F984DCCD186 @default.
- Q89918114 P2093 Q89918114-C2D5AD57-45B3-4831-A9C5-9BD27D0AD35C @default.
- Q89918114 P2093 Q89918114-C3087A08-BE49-4DF0-B3E9-1D472DE8DE8E @default.
- Q89918114 P2093 Q89918114-E0EF2BBA-D57B-4986-9ECD-30255A759F92 @default.
- Q89918114 P2093 Q89918114-EFA0B9D9-3400-4A4E-97CD-567B1FDEE940 @default.
- Q89918114 P2093 Q89918114-F35EC6EB-6CC7-47C1-9FF0-B7AF400CC224 @default.
- Q89918114 P2093 Q89918114-FFAAAB56-1AE0-4724-9396-E4829AAC06E7 @default.
- Q89918114 P304 Q89918114-466D6453-BE00-419D-914F-92671FDB0F27 @default.
- Q89918114 P31 Q89918114-9466A433-2174-4F68-B743-CEBDBE382E17 @default.
- Q89918114 P356 Q89918114-3A79F382-4D69-4E07-B54C-74680CCF4ACD @default.
- Q89918114 P478 Q89918114-E4421475-C807-451D-81BB-691FADE1BAD2 @default.
- Q89918114 P50 Q89918114-00C81FBB-E251-4F10-B8EF-9A33EF75EC26 @default.
- Q89918114 P50 Q89918114-A15E45F4-414B-4E7B-955E-51C1F527AB27 @default.
- Q89918114 P577 Q89918114-FF864B79-CB68-4A38-8D50-5854EA2D1633 @default.
- Q89918114 P698 Q89918114-6CF106B8-E375-411D-82C4-BDBF168C8EA6 @default.
- Q89918114 P921 Q89918114-85C700CB-351D-41FF-8B85-67390FCD45D2 @default.
- Q89918114 P356 J.AHJ.2020.01.009 @default.
- Q89918114 P698 32105984 @default.
- Q89918114 P1433 Q2227156 @default.
- Q89918114 P1476 "Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)" @default.
- Q89918114 P2093 "Albert T Profy" @default.
- Q89918114 P2093 "David Reasner" @default.
- Q89918114 P2093 "Gregory D Lewis" @default.
- Q89918114 P2093 "Jelena P Seferovic" @default.
- Q89918114 P2093 "John Burnett" @default.
- Q89918114 P2093 "Marvin A Konstam" @default.
- Q89918114 P2093 "Michael R Zile" @default.
- Q89918114 P2093 "Robert S Mittleman" @default.
- Q89918114 P2093 "Sanjiv J Shah" @default.
- Q89918114 P304 "183-190" @default.
- Q89918114 P31 Q13442814 @default.
- Q89918114 P356 "10.1016/J.AHJ.2020.01.009" @default.
- Q89918114 P478 "222" @default.
- Q89918114 P50 Q114304188 @default.
- Q89918114 P50 Q98243295 @default.
- Q89918114 P577 "2020-01-21T00:00:00Z" @default.
- Q89918114 P698 "32105984" @default.
- Q89918114 P921 Q269829 @default.